Conducta obstétrica ante eclampsia en primigesta de 15 años con embarazo de 36.3 semanas.
The objective of this study being to know the obstetric behavior in the face of eclampsia in a 15-year-old primigravida with a 36.3-week pregnancy, the methodology to be carried out was a retrospective and descriptive study, reviewing the clinical history of the patient who presented eclampsia at 40...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | bachelorThesis |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | http://dspace.utb.edu.ec/handle/49000/11125 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | The objective of this study being to know the obstetric behavior in the face of eclampsia in a 15-year-old primigravida with a 36.3-week pregnancy, the methodology to be carried out was a retrospective and descriptive study, reviewing the clinical history of the patient who presented eclampsia at 40 weeks of gestation, maintaining a blood pressure of 145/100 mm / Hg (HT), proteinuria three crosses (+++), and 40% edema, with a clinical picture of headache in the occipital region, blurred vision and vomiting on 10 occasions, the patient performed Tonic-clonic seizure, she received prophylactic treatment with magnesium sulfate and an emergency cesarean section was decided, with a diagnosis of eclampsia. The patient did not suffer from arterial hypertension (HT) before or during pregnancy. There was no maternal or perinatal death. Patient did not present a retroplacental hematoma, the newborn was not low weight, had Apgar 7 - 8 - 9 at birth. The incidence of eclampsia is still high in this hospital, although maternal complications are not as frequent and the perinatal results are not bad. Not all cases can be prevented with the administration of magnesium sulfate, but in severe pre-eclampsia it is an essential indication. |
|---|